Lymphangitis epidemiology and demographics: Difference between revisions
m (Bot: Removing from Primary care) |
|||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{VD}} | {{CMG}}; {{AE}}{{VD}} | ||
==Overview== | ==Overview== | ||
Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The epidemiology and demographics of this individual manifestation are poorly studied | Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The [[epidemiology]] and [[demographics]] of this individual manifestation are poorly studied | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
Lymphangitis being a manifestation of | Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The [[epidemiology]] and [[demographics]] of this individual manifestation are poorly studied. [[Epidemiology]] and [[demographics]] of lymphangitis carcinomatosis and sclerosing lymphangitis are discussed below: | ||
=== Lymphangits carcinomatosis | === Lymphangits carcinomatosis === | ||
==== Epidemiology ==== | ==== Epidemiology ==== | ||
Lymphangitis carcinomatosis occurs in 6-8% of the intra-thoracic metastasis from a malignant disease.<ref name="pmid89300342">{{cite journal| author=Bruce DM, Heys SD, Eremin O| title=Lymphangitis carcinomatosa: a literature review. | journal=J R Coll Surg Edinb | year= 1996 | volume= 41 | issue= 1 | pages= 7-13 | pmid=8930034 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8930034 }}</ref> | Lymphangitis carcinomatosis occurs in 6-8% of the intra-thoracic [[metastasis]] from a [[malignant]] disease.<ref name="pmid89300342">{{cite journal| author=Bruce DM, Heys SD, Eremin O| title=Lymphangitis carcinomatosa: a literature review. | journal=J R Coll Surg Edinb | year= 1996 | volume= 41 | issue= 1 | pages= 7-13 | pmid=8930034 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8930034 }}</ref> | ||
==== Demographically ==== | ==== Demographically ==== | ||
Higher prevalence of lymphangitis carcinomatosis is reported in male when compared to females(60:40) and younger population.<ref name="pmid89300342" /> | Higher [[prevalence]] of lymphangitis carcinomatosis is reported in [[male]]<nowiki/>s, when compared to [[females]](60:40) and younger [[population]].<ref name="pmid89300342" /> | ||
=== Sclerosing lymphangitis === | === Sclerosing lymphangitis === | ||
'''Epidemiology and demographics''' | '''Epidemiology and demographics''' | ||
Incidence and prevalence of sclerosing lymphangitis is poorly studies. Demographically, it mostly occurs in younger male population between 20-40 years of age.<ref name="pmid26228831">{{cite journal| author=Papeš D, Altarac S, Antabak A, Savić I| title=Nonvenereal sclerosing lymphangitis of the penis. | journal=Acta Dermatovenerol Croat | year= 2015 | volume= 23 | issue= 2 | pages= 150-1 | pmid=26228831 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26228831 }}</ref> | [[Incidence]] and [[prevalence]] of sclerosing lymphangitis is poorly studies. [[Demographically]], it mostly occurs in younger male population between 20-40 years of age.<ref name="pmid26228831">{{cite journal| author=Papeš D, Altarac S, Antabak A, Savić I| title=Nonvenereal sclerosing lymphangitis of the penis. | journal=Acta Dermatovenerol Croat | year= 2015 | volume= 23 | issue= 2 | pages= 150-1 | pmid=26228831 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26228831 }}</ref> | ||
== Reference == | |||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Vascular medicine]] | |||
Latest revision as of 22:36, 29 July 2020
|
Lymphangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lymphangitis epidemiology and demographics |
|
Risk calculators and risk factors for Lymphangitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Overview
Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The epidemiology and demographics of this individual manifestation are poorly studied
Epidemiology and demographics
Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The epidemiology and demographics of this individual manifestation are poorly studied. Epidemiology and demographics of lymphangitis carcinomatosis and sclerosing lymphangitis are discussed below:
Lymphangits carcinomatosis
Epidemiology
Lymphangitis carcinomatosis occurs in 6-8% of the intra-thoracic metastasis from a malignant disease.[1]
Demographically
Higher prevalence of lymphangitis carcinomatosis is reported in males, when compared to females(60:40) and younger population.[1]
Sclerosing lymphangitis
Epidemiology and demographics
Incidence and prevalence of sclerosing lymphangitis is poorly studies. Demographically, it mostly occurs in younger male population between 20-40 years of age.[2]
Reference
- ↑ 1.0 1.1 Bruce DM, Heys SD, Eremin O (1996). "Lymphangitis carcinomatosa: a literature review". J R Coll Surg Edinb. 41 (1): 7–13. PMID 8930034.
- ↑ Papeš D, Altarac S, Antabak A, Savić I (2015). "Nonvenereal sclerosing lymphangitis of the penis". Acta Dermatovenerol Croat. 23 (2): 150–1. PMID 26228831.